Short interest in Aprea Therapeutics Inc (NASDAQ:APRE) increased during the last reporting period, rising from 15.18K to 28.95K. This put 0.72% of the company's publicly available shares short.

Short interest for Aprea Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Aprea Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 43.36K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.